Journal List > J Lung Cancer > v.10(2) > 1050634

Lee, Hwang, Kim, Yoon, Lee, Lee, and Lee: Inconclusive Result from CT Guided Transthoracic Needle Aspiration and Biopsy: Affecting Factors and Final Outcome

Abstract

Purpose:

Inconclusive results from computed tomography (CT)-guided transthoracic needle aspiration and biopsy (TNAB) performed for lung lesions presents a clinical dilemma. The purpose of this study was to determine the factors affecting an inconclusive result from a CT guided TNAB, and to evaluate the final outcomes of these inconclusive results. Materials and Methods: The medical records and radiologic features of 331 patients with lung lesion who received CT guided TNAB were analyzed retrospectively. The results of the TNAB were classified as conclusive (malignancy or specific benign diagnosis) or inconclusive (nonspecific benign or nondiagnostic).

Results:

Of the 331 cases, 269 (81.3%) were diagnosed as a malignancy (210) or a specific benign lesion (59) after the first TNAB. The remaining 62 (18.7%) were inconclusive. Benign disease, a lesion size ≤15 mm, and morphology of the consolidation type were features significantly correlated with inconclusive results. Of these 62 inconclusive cases a second TNAB was performed in 23, and conclusive diagnoses were obtained in 19 (82.6%). Surgery or radiographic follow up was done in other cases. Finally, among the 62 inconclusive results on the first CT guided TNAB, 16 lesions were diagnosed as malignant, 26 were classified as specific benign disease, and the remaining 20 were defined as nonspecific inflammation. Age over 50 and morphology of a nodule or a mass type were significantly correlated with a malignancy in these 62 cases with inconclusive results on the first TNAB.

Conclusion:

A final diagnosis of benign disease was significantly higher after the CT guided TNAB was inconclusive for lesions ≤15 mm that had consolidation type morphology. Despite the application of core biopsy procedures, there continue to be appreciable numbers of inconclusive results after the first CT guided TNAB. A repeat CT guided TNAB had a high diagnostic yield in these cases and therefore should be considered for cases with inconclusive results.

REFERENCES

1. Murphy JM, Gleeson FV, Flower CD. Percutaneous needle biopsy of the lung and its impact on patient management. World J Surg. 2001; 25:373–379.
crossref
2. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003; 123(1 Suppl):115S–128S.
3. Laurent F, Latrabe V, Vergier B, Montaudon M, Vernejoux JM, Dubrez J. CT-guided transthoracic needle biopsy of pulmonary nodules smaller than 20 mm: results with an automated 20-gauge coaxial cutting needle. Clin Radiol. 2000; 55:281–287.
4. Klein JS, Salomon G, Stewart EA. Transthoracic needle biopsy with a coaxially placed 20-gauge automated cutting needle: results in 122 patients. Radiology. 1996; 198:715–720.
crossref
5. Tsukada H, Satou T, Iwashima A, Souma T. Diagnostic accuracy of CT-guided automated needle biopsy of lung nodules. AJR Am J Roentgenol. 2000; 175:239–243.
crossref
6. Yeow KM, Tsay PK, Cheung YC, Lui KW, Pan KT, Chou AS. Factors affecting diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy: retrospective analysis of 631 procedures. J Vasc Interv Radiol. 2003; 14:581–588.
crossref
7. Arslan S, Yilmaz A, Bayramgü rler B, Uzman O, Nver E, Akkaya E. CT- guided transthoracic fine needle aspiration of pulmonary lesions: accuracy and complications in 294 patients. Med Sci Monit. 2002; 8:CR493–CR497.
8. Manhire A, Charig M, Clelland C, et al. Guidelines for radio-logically guided lung biopsy. Thorax. 2003; 58:920–936.
crossref
9. Lacasse Y, Wong E, Guyatt GH, Cook DJ. Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. Thorax. 1999; 54:884–893.
crossref
10. Klein JS, Zarka MA. Transthoracic needle biopsy. Radiol Clin North Am. 2000; 38:235–266.
crossref
11. Ghaye B, Dondelinger RF. Imaging guided thoracic inter-ventions. Eur Respir J. 2001; 17:507–528.
crossref
12. Westcott JL. Percutaneous transthoracic needle biopsy. Radiology. 1988; 169:593–601.
crossref
13. Westcott JL, Rao N, Colley DP. Transthoracic needle biopsy of small pulmonary nodules. Radiology. 1997; 202:97–103.
crossref
14. Wallace MJ, Krishnamurthy S, Broemeling LD, et al. CT- guided percutaneous fine-needle aspiration biopsy of small (< or =1-cm) pulmonary lesions. Radiology. 2002; 225:823–828.
15. Greif J, Marmor S, Schwarz Y, Staroselsky AN. Percutaneous core needle biopsy vs. fine needle aspiration in diagnosing benign lung lesions. Acta Cytol. 1999; 43:756–760.
crossref
16. Savage C, Walser EM, Schnadig V, Woodside KJ, Ustuner E, Zwischenberger JB. Transthoracic image-guided biopsy of lung nodules: when is benign really benign? J Vasc Interv Radiol. 2004; 15:161–164.
crossref
17. Meyer CA. “Transthoracic needle aspiration biopsy of benign and malignant lung lesions”–a commentary. AJR Am J Roentgenol. 2007; 188:891–893.
crossref
18. Quint LE, Kretschmer M, Chang A, Nan B. CT-guided thoracic core biopsies: value of a negative result. Cancer Imaging. 2006; 6:163–167.
crossref
19. Lee IJ, Bae YA, Kim DG, et al. Percutaneous needle aspiration biopsy (PCNAB) of lung lesions: 5 years results with focusing on repeat PCNAB. Eur J Radiol. 2010; 73:551–554.
crossref
20. Khouri NF, Stitik FP, Erozan YS, et al. Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol. 1985; 144:281–288.
crossref
21. Bungay HK, Adams RF, Morris CM, Haggett PJ, Traill ZC, Gleeson FV. Cutting needle biopsy in the diagnosis of clinic-ally suspected non-carcinomatous disease of the lung. Br J Radiol. 2000; 73:349–355.
crossref
22. Hirose T, Mori K, Machida S, Tominaga K, Yokoi K, Adachi M. Computed tomographic fluoroscopy-guided transthoracic needle biopsy for diagnosis of pulmonary nodules. Jpn J Clin Oncol. 2000; 30:259–262.
crossref
23. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005; 237:395–400.
crossref
24. Oh JY, Kwon SY, Yoon HI, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer. 2007; 55:67–73.
crossref

Fig. 1.
Diagnostic algorithm of 331 patients with pulmonary lesions after a first trial of transthoracic needle aspiration and biopsy. ∗In-cluding one false positive case of adenocarcinoma which proved to be tuberculosis after surgery, Paragonimiasis, actinomycosis, non-tuberculous mycobacterium in-cluded.
jlc-10-94f1.tif
Fig. 2.
Diagnostic algorithm of lung lesions with an inconclusive first CT guided TNAB result. TB: tuberculosis, BOOP: bronchiolitis obliterans with organizing pneumonia.
jlc-10-94f2.tif
Table 1.
The Final Diagnosis in the Study Population
Final diagnosis Number (%)
Malignancy 225 (68.0)
Pulmonary tuberculosis 43 (13.0)
Pneumonia 25 (7.6)
Nonspecific inflammation 20 (6.0)
Other infection∗ 11 (3.3)
Hamartoma 4 (1.2)
Leiomyoma 1 (0.3)
BOOP 1 (0.3)
Sclerosing hemangioma 1 (0.3)

Paragonimiasis, actinomycosis, Nontuberculous mycobacteri-al disease. BOOP: bronchiolitis obliterans with organizing pneumonia.

Table 2.
Comparison of the Characteristics of the 331 Lung Lesions according to Whether the Correct Specific Diagnosis Was Made at the First CT Guided TNAB
Parameters Number Correct specific diagnosis
Success Fail p-value
Gender, M/F 331 184/85 37/25 0.189
Mean Age, yr   62.8±12.5 60.4±12.3 0.182
Age >50 yr 278 229 49 0.238
Final diagnosis       0.0001
Malignancy 225 209/225 (92.9) 16/225 (7.1)  
Benign 106 59/106 (55.7) 47/106 (44.3)  
Lesion morphology       0.0001
Nodule 124 90 (72.6) 34 (27.4)  
Mass 132 122 (92.4) 10 (7.6)  
Consolidation 32 20 (62.5) 12 (37.5)  
Cavitary lesion 24 21 (87.5) 3 (12.5)  
Ground glass opacity 19 15 (78.9) 4 (21.1)  
Lesion size, mean 331 30.7±15.3 23.5±13.5 0.001
Size over 15 mm 263 226 (85.9) 37 (14.1) 0.0001
Range of lesion size, mm       0.006
<10 12 6 6  
10∼19 81 59 22  
20∼29 85 70 15  
30∼39 76 67 9  
40∼49 38 32 6  
≥50 39 34 5  
Total 331 268 63  

Values are presented as number (%) unless otherwise indicated. CT: computed tomography, TNAB: transthoracic needle aspiration and biopsy.

Table 3.
Comparison of Characteristics of the 62 Cases Where Malignancy or Benign Disease was Finally Diagnosed after an Inconclusive First TNAB
Parameters Number Malignancy Benign p-value
Patients, n 62 16 46  
Male 39 11 (68.8) 27 (58.7) 0.425
Mean ages, yr 62 62.1±7.7 58.6±13.2 0.066
Age >50 yr 50 16 (100) 34 (73.9) 0.026
Smoking       0.390
Current or ex smoker 37 11 (68.8) 26 (56.5)  
Nonsmoker 25 5 (31.3) 20 (43.5)  
Lesion morphology       0.037
Nodule 33 9 (56.3) 24 (52.2)  
Mass 10 6 (37.5) 4 (8.7)  
Consolidation 12 1 (6.3) 11 (23.9)  
Cavitary lesion 3 0 3 (6.5)  
GGO 4 0 4 (8.7)  
Lesion size (mean), mm 62 29.3±14.6 21.5±12.6 0.046
Lesion size >15 mm 37 13 (81.3) 24 (52.2) 0.074

Values are presented as number (%) unless otherwise indicated. TNAB: transthoracic needle aspiration and biopsy, GGO: ground glass opacity.

Table 4.
Characteristics of the Subjects Who Were Diagnosed with Non-specific Inflammation
Patient number Age Sex Size (mm) Underlying disease Morphology Smoking (py) F/U duration (mo) F/U results
1 63 F 5 Melanoma Nodule 0 31 Nc
2 70 M 9   Nodule 40 27 Nc
3 45 M 5   Nodule 0 22 Decreased
4 65 F 8   GGO 0 21 Decreased
5 70 M 7 Lung cancer GGO 90 14 Disappeared
6 74 F 10 Melanoma Nodule 0 24 Nc
7 68 F 15   Nodule 0 3 Disappeared
8 62 F 10   Nodule 0 27 Nc
9 78 F 15   Nodule 0 22 Nc
10 62 F 15   Nodule 0 14 Disappeared
11 70 F 11 Lung cancer Nodule 5 13 Decreased
12 48 M 13   Nodule 45 22 Decreased
13 49 M 10   Nodule 40 25 Nc
14 69 M 13   Nodule 120 31 Nc
15 60 M 10 Lung cancer Nodule 120 31 Nc
16 35 F 27   GGO 10 25 Nc
17 67 F 32   Mass 0 24 Nc
18 62 F 35   Consolidation 0 36 Nc
19 60 M 30 Rectal cancer Cavitary Lesion 40 33 Nc
20 55 M 33   GGO 30 26 Nc

Nc: no change, GGO: ground glass opacity, py: pack year.

TOOLS
Similar articles